Lv7
4968 积分 2020-09-05 加入
The impact of second to sixth line therapy on survival of relapsed ovarian cancer after primary taxane/platinum-based therapy
6个月前
已完结
Metabolic reprogramming in cancer: signaling pathways and therapeutic targets
7个月前
已完结
Emerging trends and treatment strategies in ovarian cancer: A comprehensive review
7个月前
已完结
New insights on metabolic reprogramming in macrophage plasticity
7个月前
已完结
Metformin and caffeic acid regulate metabolic reprogramming in human cervical carcinoma SiHa/HTB-35 cells and augment anticancer activity of Cisplatin via cell cycle regulation
8个月前
已完结
[Association analysis on BRCA gene functional domain mutations and prognosis in patients with ovarian epithelial carcinoma and fallopian tube carcinoma]
10个月前
已完结
Prognostic Evaluation of Fertility-Sparing Surgery in Patients with Epithelial Ovarian Cancer: A Population-Based Analysis
11个月前
已完结
Molecular and clinical insights into early-onset endometrial cancer
11个月前
已完结
NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2025
11个月前
已关闭
B7-H3-mediated reversal of CAR-T cell exhaustion induces a notable antitumour response in ovarian cancer models
1年前
已完结